{"name":"Maher elesawi kamel elesawi","slug":"maher-elesawi-kamel-elesawi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Clomiphene citrate and Estradiol","genericName":"Clomiphene citrate and Estradiol","slug":"clomiphene-citrate-and-estradiol","indication":"Female infertility due to anovulation","status":"marketed"}]}],"pipeline":[{"name":"Clomiphene citrate and Estradiol","genericName":"Clomiphene citrate and Estradiol","slug":"clomiphene-citrate-and-estradiol","phase":"marketed","mechanism":"Clomiphene citrate acts as a selective estrogen receptor modulator to block negative feedback and increase gonadotropin secretion, while estradiol provides exogenous estrogen supplementation.","indications":["Female infertility due to anovulation","Hormone replacement therapy","Ovulation induction"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}